3 Stocks Pulling The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 28 points (-0.2%) at 17,094 as of Thursday, Aug. 28, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,204 issues advancing vs. 1,745 declining with 194 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Bio-Reference Laboratories ( BRLI), down 9.0%, Mindray Medical International ( MR), down 2.1%, Sirona Dental Systems ( SIRO), down 1.3%, Grifols ( GRFS), down 1.2% and CR Bard ( BCR), down 1.0%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Catamaran ( CTRX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Catamaran is down $0.36 (-0.8%) to $46.88 on light volume. Thus far, 325,898 shares of Catamaran exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $46.64-$47.22 after having opened the day at $47.11 as compared to the previous trading day's close of $47.23.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $9.8 billion and is part of the health care sector. Shares are down 0.5% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Catamaran a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Catamaran Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Baxter International ( BAX) is down $0.52 (-0.7%) to $74.82 on light volume. Thus far, 664,872 shares of Baxter International exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $74.63-$75.19 after having opened the day at $75.11 as compared to the previous trading day's close of $75.34.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $40.9 billion and is part of the health care sector. Shares are up 8.3% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is down $0.72 (-1.0%) to $74.00 on light volume. Thus far, 1.4 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.8 million shares. The stock has ranged in price between $73.95-$74.87 after having opened the day at $74.61 as compared to the previous trading day's close of $74.72.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $56.0 billion and is part of the health care sector. Shares are up 6.4% year-to-date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Express Scripts Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

As Cyberattacks Rise, This Is Why CEOs Might Want to Prepare for the Worst and Buy Bitcoins

As Cyberattacks Rise, This Is Why CEOs Might Want to Prepare for the Worst and Buy Bitcoins

The Price of Bitcoin May Be Rising Because of This One Factor

The Price of Bitcoin May Be Rising Because of This One Factor

Crude Surge Marches Dow to Near Record Close

Crude Surge Marches Dow to Near Record Close

Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More

Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound